{
    "nct_id": "NCT04114370",
    "official_title": "Evaluation of 18F-fluciclovine (FACBC) PET/MR Uptake in Participants With Glioma",
    "inclusion_criteria": "* 1. Age â‰¥ 18 years old.\n\n  2. Been previously diagnosed by resection or biopsy with grade 3 or 4 glioma.\n\n  3. Agree to use adequate contraception as indicated in this protocol.\n\n  4. Consent to PET scanning and receipt of one injection of 18F-fluciclovine.\n\n  5. Able to comply with study procedures.\n\n  6. Able to give written consent.\n\n  7. Subject has had a standard of care, diagnostic MRI study which was indeterminate due to the inability to differentiate pseudoprogression versus tumor progression.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* 1. Are a pregnant or breastfeeding female.\n\n  2. Are participating in a clinical trial of another unlicensed product.\n\n  3. Are undergoing 18F-fluciclovine PET for reason(s) other than newly diagnosed or recurrent glioma.\n\n  4. Have a hypersensitivity to 18F-fluciclovine.\n\n  5. Have acute renal failure or moderate/severe renal impairment, according to local clinical guidelines.\n\n  6. Have a non-MRI compatible implantable device or another contraindication for MRI scan.\n\n  7. Are deemed ineligible to participate for other reasons by an investigator.",
    "miscellaneous_criteria": ""
}